The chronic caseload private clinics actually see

Ethiopia's health system was built around infectious disease and maternal care, and the national indicators still reflect that. But the caseload walking into an urban private clinic increasingly does not.

What the population data shows

A population-based study across the Addis Health and Demographic Surveillance System found that 11.5% of adults (95% CI 11.3–11.7) reported at least one chronic non-communicable disease 1. The two leading conditions:

Counts people who know they have the condition, so each bar is a floor on the true burden.

Source: Abdelmenan et al. 2024 [1]

Show data table

	Self-reported chronic NCD prevalence, Addis-HDSS adults
Any chronic NCD	11.5%
Hypertension	5.9%
Diabetes mellitus	3.4%

Prevalence rose steeply with age and was higher among those with no formal education and in higher wealth quintiles 1:

Adjusted incidence rate ratios with 95% confidence intervals; 1.0 means no association.

Source: Abdelmenan et al. 2024 [1]

Show data table

	Estimate	95% CI
Older age	5.47	5.17–5.79
Formerly married	2.68	2.47–2.91
No formal education	1.58	1.45–1.72
Higher wealth quintile	1.16	1.07–1.26

The wealth association is the one worth pausing on for a private clinic: higher-income households report more diagnosed NCD, which is at least partly a detection effect — they are the households most likely to have been screened.

Comorbidity is the normal case

Among Ethiopians already diagnosed with type 2 diabetes, a meta-analysis of six studies found pooled hypertension prevalence of 55% (95% CI 49–61) 2, with a regional subgroup estimate of 51% (95% CI 42–59) in Oromia and Southern regions 2.

Pooled across six studies; the regional subgroup covers Oromia and Southern regions.

Source: Haile et al. 2023, meta-analysis [2]

Show data table

	Hypertension among Ethiopian type 2 diabetes patients
Pooled national estimate	55%
Oromia and Southern regions	51%

So the modal chronic patient is not managing one condition on one medication. They are managing two, on multiple medications, with two sets of monitoring targets — and, in a paper system, often two separate cards.

Why this caseload strains paper workflows

NCD care has three properties that acute care does not:

1. It never discharges. The patient is on the books indefinitely, so the record has to remain findable for years, not weeks.
2. It is appointment-driven. Control depends on regular review, which means the clinic's ability to schedule and recall is part of the clinical intervention. Ethiopian evidence on that is blunt: 39.2% of hypertensive patients in South Gondar follow-up clinics were non-adherent to their appointments, with pill burden (AOR 3.50) and absence of perceived symptoms (AOR 4.98) among the strongest predictors 3.
3. It is medication-dependent. Continuity depends on the drug being in stock on the day, every time — an inventory problem as much as a clinical one.

Each property is a place where a paper-based clinic loses information: a card that cannot be found, a follow-up nobody flagged, a refill nobody anticipated.

What follows for a clinic

• Track the cohort, not the visit. The unit of management for NCD care is the patient across a year, which is not what a daily register is shaped to produce.
• Expect comorbidity by default. With hypertension at 55% among type 2 diabetes patients 2, a chart design that treats one condition as the record and the other as a note will lose the second one.
• Treat "no symptoms" as a defaulting risk. It is the single strongest predictor of missed follow-up in the South Gondar data (AOR 4.98) 3 — precisely because controlled patients feel fine.

What this note does not claim

The Addis-HDSS figure is self-reported prevalence — it counts people who know they have the condition 1. Measured prevalence in screening studies runs higher, so 11.5% is a floor on the true burden, and the gap between them is undiagnosed disease of unknown size. The study is also confined to Addis Ababa and does not generalise to rural Ethiopia.

The hypertension figure in reference 2 is prevalence among diagnosed type 2 diabetes patients, drawn from facility-based studies — it is not a population prevalence for either condition, and it rests on only six included studies. General-population prevalence estimates for hypertension and diabetes in Ethiopia vary widely by measurement method, and we have deliberately not quoted a single pooled number for them here.